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The small heat-shock protein HSP25 is expressed in the heart early during development, and although multiple roles for
HSP25 have been proposed, its specific role during development and differentiation is not known. P19 is an embryonal
carcinoma cell line which can be induced to differentiate in vitro into either cardiomyocytes or neurons. We have used P19
to examine the role of HSP25 in differentiation. We found that HSP25 expression is strongly increased in P19
cardiomyocytes. Antisense HSP25 expression reduced the extent of cardiomyocyte differentiation and resulted in reduced
expression of cardiac actin and the intermediate filament desmin and reduced level of cardiac mRNAs. Thus, HSP25 is
necessary for differentiation of P19 into cardiomyocytes. In contrast, P19 neurons did not express HSP25 and antisense
HSP25 expression had no effect on neuronal differentiation. The phosphorylation of HSP25 by the p38/SAPK2 pathway is
known to be important for certain of its functions. Inhibition of this pathway by the specific inhibitor SB203580 prevented
cardiomyocyte differentiation of P19 cells. In contrast, PD90589, which inhibits the ERK1/2 pathway, had no effect.
Surprisingly, cardiogenesis was only sensitive to SB203580 during the first 2 days of differentiation, before HSP25 expression
increases. In contrast to the effect of antisense HSP25, SB203580 reduced the level of expression of the mesodermal marker
Brachyury-T during differentiation. Therefore, we propose that the p38 pathway acts on an essential target during early
cardiogenesis. Once this initial step is complete, HSP25 is necessary for the functional differentiation of P19 cardiomyo-
cytes, but its phosphorylation by p38/SAPK2 is not required. © 2000 Academic Press
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myocardium.INTRODUCTION
HSP25 is one of a family of six small heat-shock proteins
(smHSP) in mammals. It is developmentally regulated (Ger-
nold et al., 1993) and accounts for about 0.2% of protein
expressed in the adult mouse heart, as well as being highly
expressed in skeletal muscle and in epidermal cells, some
neurons, and the lens (Gernold et al., 1993; Klemenz et al.,
1993; reviewed in Loones et al., 1997). Although HSP25
expression has been found to correlate with the differentia-
tion of numerous cell culture lines tested in vitro (e.g.,
Minowada and Welch, 1995; Spector et al., 1995), its role in
this process is unknown. It has been shown to be a chaper-
one (Lee et al., 1995; Ehrnsperger et al., 1997), to confer
resistance to apoptosis (Mehlen et al., 1996), and it has an in
vitro actin-capping activity (Lavoie et al., 1993, 1995;
1 To whom correspondence should be addressed. Fax: (33)
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146Benndorf et al., 1994) which is apparently essential in vivo
for actin reorganization and migration of endothelial cells
in response to vascular endothelial growth factor (VEGF)
(Rousseau et al., 1997) or in an in vitro wounding assay
(Piotrowicz et al., 1998). More recently, an important func-
tion in maintaining intermediate filament networks has
been discovered for another member of the smHSP family,
aB-crystallin (Nicholl and Quinlan, 1994; Djabali et al.,
1997), and a mutation in this gene has been established as
the cause of a familial desmin-related cardiomyopathy
(Vicart et al., 1998). This function does not seem to be
restricted to the crystallin isoform, since aB-crystallin and
HSP25 have been shown to interact with each other
(Boelens et al., 1998), are both found in inclusion bodies
with glial fibrillary acidic protein (GFAP) when GFAP is
overexpressed (Koyama and Goldman, 1999), and both
smHSPs colocalize with GFAP, desmin, or vimentin
(Wisniewski and Goldman, 1998; van den IJssel et al., 1999).Serine phosphorylation of HSP25 causes it to change from
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147HSP25 and Differentiationmultimers to dimers (Lambert et al., 1999), but there is
evidence both for (Huot et al., 1996; Lavoie et al., 1995), and
against (Knauf et al., 1994; Preville et al., 1998), the require-
ment of HSP25 phosphorylation for its functions. HSP25 is
phosphorylated by the kinases MAPKAPK-2 (MAPK-
activated protein kinase 2) (Huot et al., 1995), MAPKAPK-3
(McLaughlin et al., 1996), and PRAK (New et al., 1998), and
these are activated by p38/SAPK2. p38 is the third type of
mitogen-activated protein kinase (MAPK) to have been
discovered in mammalian cells and, like JNK/SAPK1
(stress-activated protein kinase 1), it was initially demon-
strated to be activated by the treatment of cells with
various stresses or inflammatory cytokines (Raingeaud et
al., 1995; Rouse et al., 1994). A number of other target
proteins of p38 have been identified, chiefly transcription
factors such as ATF2, CHOP/GADD153 (Wang and Ron,
1996), and MEF2C (Yang et al., 1999), in monocytes (Han et
al., 1997) as well as in muscle cells (Zhao et al., 1999).
Recently, p38 has been shown to be essential for the
terminal differentiation of skeletal muscle cell lines
(Cuenda and Cohen, 1999; Zetser et al., 1999) and evidence
was presented which implicates the muscle-specific tran-
scription factor MEF2C, a target for p38, in the induction of
creatine kinase transcription by p38 (Zetser et al., 1999).
The role of p38 in heart development has not previously
been assessed. Although cardiomyocytes and skeletal myo-
cytes are similar in many respects—for instance, they
express similar contractile proteins—their developmental
pathways differ significantly. Cardiomyocytes originate
from different progenitor cells, continue to proliferate dur-
ing initial steps of differentiation, and MyoD-related
b-helix–loop–helix transcription factors are not involved in
their differentiation. It seemed likely that p38 would be
involved in cardiogenesis; however, since there is strong
evidence that p38 is involved in at least some aspects of
cardiomyocyte hypertrophy (reviewed in Sugden and Clerk,
1998). In this situation, induced during some pathological
conditions, cardiomyocytes reenter a growth program very
similar to that observed during embryogenesis. Activation
of p38 in cardiac myocytes by transfection with activated
MKK6 or by treatment with phenylephrine induces the
typical sarcomeric reorganization, reexpression of embry-
onic sarcomeric isoforms, and increase in cell size which
are observed during cardiac hypertrophy (Zechner et al.,
1997). This effect may be limited to p38b, since transfection
of cardiomyocytes with activated p38a leads to cell death
y apoptosis (Wang et al., 1998). Other MAPK pathways
ay also be involved in hypertrophy; for example, JNK/
APK1 activation appears to suppress its development
Nemoto et al., 1998). Further complicating the issue is the
bservation that inhibition of the p38 pathways does not
ffect the initial morphological changes of endothelin-1-
nduced hypertrophy, but may be necessary over a longer
eriod of time to maintain the response (Clerk et al., 1998).
nterestingly, HSP25 was rapidly phosphorylated after en-
othelin treatment, and this was suggested to assist in the
aintenance of the morphological change (Clerk et al.,
Copyright © 2000 by Academic Press. All right998). Levels of HSP25 are also found to be increased in
ailing, hypertrophic human hearts (Knowlton et al., 1998).
Since HSP25 is involved in the control of cytoskeletal
tructure and highly expressed in the heart, and since the
38 pathway has been shown to be involved in the differ-
ntiation of skeletal muscle cells, we decided to look at the
ole of HSP25 and p38 in a model of cardiogenesis, the P19
ell line.
P19 cells are a multipotent embryonal carcinoma cell line
reviewed in McBurney, 1993) which differentiate in vitro
nto neurons when grown as aggregates in the presence of
etinoic acid. In the presence of 1% DMSO, the accumula-
ion of Brachyury-T mRNA indicates the presence of me-
odermal cells (Pruitt, 1994; Vidricaire et al., 1994) and by
day 6 rhythmically contracting cardiomyocytes arise in the
interior of aggregates. At later time points (about day 10),
skeletal muscle develops. In all aggregates, including those
not treated with inducer, cells resembling primitive ex-
traembryonic endoderm initially develop at the periphery of
aggregates at day 2 to day 3. We found that HSP25 expres-
sion and p38 activity are both required for P19 to form
functional cardiomyocytes.
MATERIALS AND METHODS
Cell Culture and Differentiation
P19 cells (obtained from F. Loubet, Institut de Myologie, Paris,
France) were cultured at 37°C in 7.5% CO2 water-saturated atmo-
sphere in RPMI medium (Gibco) containing 15% heat-inactivated
fetal calf serum, 50 mg/ml streptomycin, and 50 units/ml penicil-
lin, b-mercaptoethanol, and pyruvate. To ensure homogeneity of
the cells, a single cell clone of P19 was isolated by limiting dilution
and used for all experiments. Cells were not kept in culture longer
than 2 months at a time.
Differentiation into cardiomyocytes for protein and RNA extrac-
tion was performed by the method of “bulk culture,” essentially as
described in McBurney et al. (1982). Briefly, 106 cells were plated in
10-cm tissue culture dish overnight to ensure that they were in
ogarithmic growth and because we found that cell density can
ffect basal HSP25 levels. Cells were trypsinized and replated in
ifferentiation medium (as per growth medium except with 20%
eat-inactivated fetal calf serum and with the addition of 1%
MSO) at 2 3 104 cells per milliliter in bacterial dishes. In
ccordance with ES cell differentiation procedures, this day was
alled “day 1.” On day 4, cell aggregates were pipetted into 15-ml
onical tubes and the aggregates left to settle by gravity. The
edium was aspirated and cells were transferred to 6-cm tissue
ulture dishes in fresh differentiation medium lacking DMSO.
eating regions appeared in the aggregates by day 6 to day 7, and
ells were typically harvested on day 8. Skeletal muscle appears in
ultures at day 10 of DMSO differentiation.
For quantitation of cardiac differentiation, the “hanging drops”
ethod described in Smith et al. (1987) was used. This is identical
o the bulk aggregate method except that on day 1, fifty 20-ml drops
of cells were pipetted onto the roof of a bacterial dish, and then this
was inverted over PBS (to maintain humidity). On day 4, the drops
were collected, the medium was replaced, and cells replated as
described above. On day 8, the percentage of aggregates per dish
containing a region of any size which was beating were scored.
s of reproduction in any form reserved.
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148 Davidson and MorangeDuplicate samples were counted in each experiment, and differen-
tiation experiments were verified at least twice.
For neuronal differentiation cells were treated as above, except
with 0.3 mM retinoic acid in place of DMSO.
SB203580 and PD90589 (Calbiochem, La Jolla, CA), were added
at 10 and 25 mM, respectively, at the time points indicated in the
ext. In the experiment where SB203580 was washed from the cells
efore they were plated on day 4, all samples were incubated in
bulk culture.”
Transfection
Cells were transfected by CaPO4 precipitation using the plasmid
pKJ23 encoding hygromycin resistance alone or with a 10-fold
excess of the expression vector pSVK3 (Pharmacia, Sweden) engi-
neered to contain the murine HSP25 cDNA in sense (pSVK-WT) or
antisense (pSVM) direction under the control of the SV40 promoter
(Knauf et al., 1994). Resistant cells were selected in 500 mg/ml
ygromycin and single clones were isolated and tested for the level
f HSP25 protein by immunoblot. Numerous pSVM-containing
lones were isolated with decreased expression of HSP25 and two
ere chosen for analysis. From numerous potential HSP25-
verexpressing clones with pSVK-WT, two were chosen which gave
he most reproducible increase of HSP25 on immunoblots.
Immunohistochemistry
Cells for immunohistochemistry were plated on gelatin-coated,
sterile glass coverslips at day 4 during the differentiation procedure
and harvested at day 8 by washing in 4°C PBS and then fixed in
220°C 100% methanol on ice for 20 min. Coverslips were dried
and stored. Immunohistochemistry of coverslips was performed in
a humid chamber. Coverslips were blocked for 1 h in 3% BSA in
PBS and then incubated with primary antibody in 3% BSA/PBS for
1 h. The coverslips were washed four times in PBS and then
incubated with secondary antibody and Hoechst 33258 for 30 min.
After being washed four times in PBS, coverslips were mounted on
slides with Mowiol, dried overnight, and examined on a Leica
DMRB microscope. Photographs were taken with Kodak 1600 film,
and these were scanned and images assembled using Photoshop and
Canvas. Antibodies and dilutions used were 1:100 anti-HSP25
(SPA-801, Stressgen); 1:500 anti-cardiac actin (clone 5C5, Sigma);
1:400 TuJ1 (Frankfurter); 1:400 SSEA-1 (MC480, DSHB); 1:250
MF-20 (DSHB); 1:100 anti-desmin (MP760, DAKO); and 100%
TROMA-1 hybridoma supernatant (DSHB). Secondary antibodies
used were 1:400 CY3-goat anti-rabbit (Interchim) and 1:100 FITC
goat anti-mouse (Sigma). For double staining using TROMA-1 and
anti-HSP25, these were added together in a 1 h primary reaction,
and then 1:400 CY3-goat anti-rabbit was added for 30 min and
washed off and replaced with 1:200 FITC rabbit anti-rat. No
cross-reaction was observed in control incubations omitting either
primary antibody. For quantitation, at least 100 cells were scored,
and the average and standard error of the mean over different slides
were calculated.
Gel Electrophoresis and Immunoblotting
Protein extracts were prepared by washing cells in 4°C PBS,
scraping into Laemmli sample buffer, and then heating for 10 min
at 90°C (Laemmli, 1970). Aliquots were assayed for protein con-
centration using the Bio-Rad protein assay kit (Bio-Rad) and equal
amounts of protein (usually 40 mg) were loaded per well on an
Copyright © 2000 by Academic Press. All rightDS–15% polyacrylamide gel. Prestained low-range SDS–PAGE
tandards from Bio-Rad were used. As an internal control of HSP25
mmunoblots, 100 ng purified HSP25 (SPP-710, StressGen, Canada)
as run with the standards.
Proteins were electrotransferred on Hybond-ECL nitrocellulose.
qual loading of protein was verified by staining of the membrane
ith Ponceau red. Immunoblots were performed as described in the
CL kit (Amersham Corp.). Antibodies used were 1:5000 anti-
SP25 (SPA-800, Stressgen) and 1:5,000 TuJ1 (Frankfurter). In each
ase, the appropriate peroxidase-conjugated secondary antibody
as used at 1:10,000.
RNA Extraction and RT-PCR
RNA was extracted from cells using the RNA-plus kit from
Quantum Bioprobe. Contaminating DNA was digested by DNase
treatment (Promega) as recommended by the manufacturer. Re-
verse transcription was performed on 5 mg RNA using 1.5 mM
oly(dT)15 primer and 50 U AMV reverse transcriptase (Promega) at
2°C for 60 min in a volume of 25 ml, as per the recommendations
f the manufacturer. Aliquots of 1 ml and fivefold serial dilutions
ere used in a 25-ml PCR reaction mixture containing 12.5 mM
primers, 1–3 mM MgCl2, 2 mM dNTPs, Tfl reaction buffer, and
2.5 U Tfl polymerase. PCR commenced with 94°C for 2 min; then
5–30 cycles of 94°C for 25 s, 60°C for 30 s, 72°C for 1 min; and
nished with 72°C for 6 min. Fifteen microliters of the reaction
as run on a 2% agarose gel in 0.53 TBE and photographed on a UV
ransilluminator using a digital camera. Primers were as previously
ublished: cardiac-actin (Lyons et al., 1995), ANF, Brachyury-T,
esmin, GAPDH, and MLC-2a (Xu et al., 1999). The relative
expression levels of mRNAs in different samples were determined
by quantitating the intensity of the ethidium-bromide-stained
bands using NIH Image and calculating the fold dilution of starting
material which would be required for similar signal intensities.
RESULTS
HSP25 Levels Increase during Cardiomyocyte
Differentiation
P19 cultures were grown as aggregates in bacterial dishes
from day 1 in the presence of 1% DMSO and then plated in
cell culture-treated dishes on day 4 without DMSO. Rhyth-
mically beating regions were detectable by microscopic
examination from day 6. The number of beating regions did
not change greatly after day 8, and this time point was
chosen for future analyses (below). By immunoblot, HSP25
levels were observed to diminish during early differentia-
tion, but increased dramatically in parallel with the appear-
ance of contracting cardiomyocytes in the P19 culture (Fig.
1A). In contrast, HSP25 did not alter during neuronal
differentiation (in the presence of retinoic acid) (Fig. 1B) nor
when cells were differentiated primarily into endodermal
cells by aggregation in the absence of inducer (Fig. 1C). The
development of neurons was confirmed by microscopic
observation of the formation of neurites in the differenti-
ated cultures and is illustrated here by the appearance of a
neuron-specific tubulin isoform, detected on an immuno-
blot by the antibody TuJ1 (Fig. 1B). The TROMA-1 antibody
was used to follow the synthesis of cytokeratin 8 interme-
s of reproduction in any form reserved.
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149HSP25 and Differentiationdiate filament (EndoA) during endodermal differentiation
(Brulet et al., 1980) (Fig. 1C). We verified that treatment of
P19 cells in monolayer with DMSO had no effect on HSP25
levels, nor did it induce visible signs of differentiation (data
not shown).
Cardiomyocytes but Not Neurons Express High
Levels of HSP25
Since the cultures of differentiated P19 are heteroge-
neous, with approximately 5–10% cardiomyocytes or neu-
rons, depending on the differentiation conditions, cultures
were fixed at day 8 and doubly stained with antibodies
against HSP25 and various differentiation markers. In each
case we selected fields which were full of cells so that a
comparison can be made between the level of staining in
cells positive for the marker and those which are negative.
There was a strong correlation between HSP25 and cardiac
actin (Figs. 2A and 2B), confirming that the cardiomyocytes
FIG. 1. The level of HSP25 varies during cardiomyocyte differen-
tiation of P19 cells but not during neuronal or endodermal differ-
entiation. Multiple dishes of P19 cells were differentiated in bulk
cultures as described under Materials and Methods and plated in
tissue culture dishes at day 4 (indicated by an arrow). On the days
indicated, samples were harvested and 40 mg of each sample was
run on 15% SDS–PAGE. The levels of HSP25 and differentiation
markers TuJ1 and TROMA-1 were detected on immunoblots.synthesize the HSP25 detected by immunoblot. On average,
Copyright © 2000 by Academic Press. All right8 6 1% of cardiomyocytes (i.e., cells expressing cardiac
ctin) also expressed HSP25. In contrast, 14 6 5% of
SP25-positive cells in cardiac regions did not visibly
xpress cardiac actin, perhaps indicating that HSP25 is a
arker of early cardiomyocyte differentiation which is
xpressed before cardiac actin.
At later differentiation times, skeletal muscle was de-
ected in the cultures using the anti-myosin antibody
F-20, and these cells also expressed HSP25 (Figs. 2C and
D), although the correlation was less dramatic.
In contrast to cardiomyocyte differentiation, the HSP25
FIG. 2. HSP25 is expressed in differentiating cardiomyocytes and
skeletal muscle but not in neurons. Hanging drop cultures of P19
cells were differentiated in 1% DMSO for differentiation of muscle
(A–D) or 0.3 mM retinoic acid for differentiation of neurons (E, F)
and then plated on gelatin-coated coverslips at day 4. After fixation
in 100% methanol at 220°C on day 8 (or day 10 for skeletal
muscle), they were doubly stained with antibodies against HSP25
and a differentiation marker—cardiac actin (A, B), MF-20 (C, D), or
TuJ1 (E, F). The entire field of each figure was filled with cells. Bar,
100 mm.
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150 Davidson and Morangein neuronal cultures was not localized to neurons express-
ing a neuronal-specific form of tubulin (Figs. 2E and 2F).
Developing neuronal cultures of P19 were also fixed at
earlier time points, and although some TuJ1-positive neu-
rons were visible with short neurites by day 5, they con-
tained no detectable HSP25.
The HSP25 protein detected by immunoblot of differen-
tiating P19 neurons and endodermal cells (Figs. 1B and 1C)
apparently derives at least partly from HSP25-positive cells
on the periphery of aggregates, which were also observed in
developing cardiomyocyte cultures. These cells are most
likely to be endodermal cells, since about 75 6 6% of them
lso stained positive with the endodermal marker
ROMA-1 (data not shown).
The contraction of cardiomyocytes can induce the ex-
ression of certain cardiac muscle genes such as myosin
eavy chain-b and ANF (atrial natriuretic factor—a
olypeptide produced by cardiomyocytes) (Eble et al., 1998;
amarel and Engelmann, 1991), and the level of HSP27 has
een shown to be increased by continuous low-frequency
otor nerve stimulation of skeletal muscle (Neufer and
enjamin, 1996). P19 were differentiated in the presence of
hree inhibitors of cardiac contraction which function in
ifferent manners (verapamil, 2,3-butanedione monoxime,
r potassium chloride), but the correlation of HSP25 with
he expression of cardiac actin was unchanged, indicating
hat contraction was not necessary for HSP25 induction
data not shown).
HSP25 Is Necessary for Cardiomyocyte
Differentiation but Not Proliferation
In order to test whether HSP25 is essential for P19
differentiation, they were cotransfected with murine
HSP25 or antisense HSP25 plus a hygromycin resistance
vector and individual hygromycin-resistant clones were
isolated. In several antisense clones, the basal level of
HSP25 protein was significantly reduced, as shown in a
HSP25 immunoblot (Fig. 3). Overexpression of HSP25 was
FIG. 3. HSP25 levels are altered in transfected P19 cells. HSP25
rotein was detected on an immunoblot of clones of P19 trans-
ected with a plasmid conferring hygromycin resistance and pSVK3
ector alone (vector) or additionally containing the HSP25 cDNA
n antisense (clones AI and AM) or sense (clones S2D, S2C, and SU)
irection. P19 cells are included as a control (P19). An antibody
gainst HSP84 (the constitutive isoform of HSP90) confirmed equal
rotein loading.more difficult to achieve in P19 cells, which already express
Copyright © 2000 by Academic Press. All rightubstantial amounts of this protein. Although several resis-
ant clones were isolated and selected on the basis of their
igher level of HSP25 on immunoblot (Fig. 3), the level
aried somewhat between experiments, possibly indicating
egulation at a posttranscriptional level as has been ob-
erved for the smHSP in Drosophila and chicken (Edington
nd Hightower, 1990; Michaud et al., 1997).
Chaufour et al. (1996) found no change in proliferation
ate of HL-60 transfected with antisense HSP25, but others
ave observed an altered growth rate (Kindas-Mugge et al.,
996, 1998; Mairesse et al., 1996). Since aggregate size may
nfluence differentiation, the growth rate of clones was
ested by plating multiple dishes at low density and count-
ng cell numbers at 12-h intervals, but no difference in
rowth rate was detected between antisense and control
lones (data not shown).
The ability of each of the clones to differentiate into
unctioning cardiomyocytes was tested by scoring the per-
entage of aggregates which formed beating regions. Figure
illustrates that antisense clones were poor at differentiat-
ng, although P19 containing the hygromycin selection
arker alone or overexpressing HSP25 were unaffected. By
ight microscopy, the size and morphology of aggregates of
ll clones appeared identical to aggregates of nontransfected
19. Similarly, differentiated cultures of all clones dis-
layed heterogeneous differentiated morphologies which
re readily distinguishable from the smaller, more regular-
FIG. 4. Clones expressing antisense HSP25 are affected in their
capability to differentiate into cardiomyocytes. Differentiation
into beating cardiomyocytes was compared between untransfected
P19 cells (P19), P19 containing the empty vector and hygromycin
resistance vector (vector), P19 cells aggregated in the absence of
DMSO (no DMSO), and different sense and antisense clones
(labeled as per Fig. 3). Duplicate dishes of each clone were differ-
entiated as described in the legend to Fig. 2, until day 4, when they
were plated in normal tissue culture dishes. On day 8, the percent-
age of colonies with any rhythmically contracting regions detect-
able light microscopically was scored. Similar results were ob-
tained in multiple experiments.
s of reproduction in any form reserved.
t
P
b
w
d
l
a
8
t
s
o
s
s
S
d
c
t
s
w
c
a
151HSP25 and Differentiationshaped nondifferentiated P19 cells. Furthermore, in differ-
entiated cultures of all clones the majority of cells lacked
the embryonic SSEA-1 epitope, which is a cell surface
antigen expressed only on embryonal cells (Solter and
Knowles, 1978). In control experiments, the SSEA-1 anti-
body strongly stained nondifferentiated P19 cells (data not
shown). At later time points, small regions of beating cells
appeared in most aggregates, thereby increasing the “per-
centage differentiation” to almost normal levels, but by
microscopic examination it was obvious that the extent of
beating regions was still dramatically less than in normal
P19 cells.
To establish at exactly which step differentiation was
interrupted, we reverse transcribed the RNA and amplified
the cDNA corresponding to various differentiation markers
by semiquantitative RT-PCR, comparing P19 cells before
(day 1) and after (day 7) differentiation and a differentiated
antisense clone (day 7). The quantity of input cDNA was
adjusted until GAPDH was amplified to the same extent in
each sample. The cardiac markers tested could not be
detected in cDNA from undifferentiated P19 control cells
in monolayer (Fig. 5A), and all were present at significantly
reduced levels in antisense clone AI compared to P19 at the
same stage of cardiomyocyte differentiation, particularly
desmin and actin (Figs. 5B and 5D). The mRNA for the
mesodermal marker Brachyury-T is maximally expressed at
day 3 during P19 differentiation and then returns to basal
levels shortly afterward (Pruitt, 1994; Vidricaire et al.,
1994). In RNA from aggregates sampled at day 3 we found
the same level of Brachyury-T expression in both P19 and
antisense clone AI (Figs. 5B and 5D), which indicates that
the early step of mesodermal differentiation is unaffected in
the antisense clone. These results were confirmed with
separately generated cDNA and with cDNA from another
antisense clone, AM (data not shown).
Immunofluorescence studies confirmed that HSP25 lev-
els were reduced in the cardiomyocytes formed from anti-
sense clones (Fig. 6C) and highly expressed in sense clones
(Fig. 6F). Many fewer cells staining with the cardiac actin
antibody were detected in the differentiated antisense
clones, and in these cells the level of c-actin expression
appeared to be reduced (compare Fig. 6D to Fig. 2A). It was
more difficult to observe a correlation between the expres-
sion of HSP25 and cardiac actin in differentiated antisense
clones due to the low levels of these proteins (Fig. 6E). The
expression of the muscle-specific intermediate filament,
desmin, was also dramatically reduced in antisense clones
and appeared to have a different structure to the desmin in
cardiomyocytes of P19 and sense clones (Fig. 7), perhaps
indicating a requirement for HSP25 to assist in the main-
tenance of the intermediate filament network.
The p38 Pathway Is Necessary for Cardiomyocyte
Differentiation
HSP25 is phosphorylated by the MAPK pathway involv-
ing p38/SAPK2, which can be specifically inhibited using
Copyright © 2000 by Academic Press. All righthe drug SB203580 (reviewed in Cohen, 1997). Treatment of
19 with SB203580 dramatically reduced the number of
eating regions detected (Fig. 8). Unexpectedly, inhibition
as complete even when the drug was added very early
uring the differentiation procedure and removed when
evels of HSP25 were still low (Fig. 8). In contrast, when
dded at day 4 or day 6, differentiation was unaffected (Fig.
) which demonstrates that the inhibition of p38 at early
ime points is not simply persisting until a critical later
tage and also that p38 is not required for the establishment
f functional contracting actomyosin structures at this late
tage. SB203580 did not inhibit all differentiation in DMSO,
ince by day 8 colonies were completely negative for
SEA-1 (data not shown). But in comparison to untreated
ifferentiated cultures, many fewer cells were positive for
-actin (Fig. 6B) or desmin (data not shown), and although
hese cells were also positive for HSP25, the levels of HSP25
eemed lower and no longer overlapped quite so precisely
ith c-actin expression (Figs. 6A and 6B). The percentage of
ells positive for HSP25 but which did not express cardiac
ctin was found to have increased to 35 6 8% (compared to
14 6 5% in control cultures). Treatment of P19 cells with
SB203580 during the entire period of cardiomyocyte differ-
entiation resulted in a reduction in the levels of mRNA for
the cardiac markers examined to a similar extent to that
which was observed in the antisense clone (Figs. 5B–5D).
However, in the case of SB203580 treatment, a consistent
reduction in Brachyury-T mRNA levels was observed. Since
Brachyury-T was not reduced to background levels,
SB203580 apparently reduces or delays differentiation of
P19 into mesodermal cells, but does not entirely block it.
The effect of SB203580 was specific, since inhibiting
activation of the “classical” MAPK pathway of ERK1/ERK2
with PD98059 had no effect on cardiomyocyte differentia-
tion (Fig. 8A). Furthermore, SB203580 does not negatively
affect all differentiation pathways, since differentiation of
P19 cells into neurons in the presence of SB203580 resulted
in an apparent increase in neuronal differentiation as deter-
mined by immunofluorescence (Figs. 9A and 9B) and a
greatly increased amount of neuronal marker detected by
TuJ1 on an immunoblot (Fig. 9C).
DISCUSSION
The Role of HSP25 in Cardiomyocyte
Differentiation
The myocardial lineage derives from mesodermal cells
which start to express the Brachyury-T gene on day 7
postcoitum in the mouse embryo (Wilkinson et al., 1990).
On day 8 the primordial linear heart tube develops from the
splanchnic mesoderm, by which time expression of the
MEF2C transcription factor is detected in myocardium
(Edmondson et al., 1994). Cardiomyocytes within the tube
start beating rhythmically on day 8.5, which is also when
HSP25 protein can first be detected (M. T. Loones, S. M.
Davidson, and M. Morange, unpublished results). Looping
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All rightof the heart tube also begins at this time, followed by the
morphological changes which will lead to a four-chambered
heart. HSP25 remains expressed in the myocardium
throughout development but is found at lower levels in the
adult heart. Considering its early and specific expression
during cardiogenesis, it seemed likely that HSP25 would be
involved in the differentiation of cardiomyocytes. Here we
have used an in vitro system which therefore excludes the
study of morphological aspects of development but which
FIG. 6. The intensity of actin staining is altered in antisense
clones and in P19 cells treated with SB203580. Hanging drop
cultures of P19, antisense clone AI, and sense clone S2C were
differentiated as described in the legend to Fig. 2 and then doubly
stained with antibodies for HSP25 (A, C, F) and cardiac actin (B, D,
G). (E) Double exposure illustrating that cardiac actin (green) is
roughly associated with the remaining HSP25 (red) expression in
clone AI. The entire field of each figure was filled with cells.
Bar, 50 mm.
the PCR reaction was run on a 2% agarose gel containing ethidium
bromide and photographed using a digital camera. cActin, cardiac
actin; ANF, atrial natriuretic factor; MLC-2a, myosin light chainFIG. 5. Semiquantitative RT-PCR reveals a reduction in the
levels of cardiac differentiation markers. (A) P19 cells before
differentiation. (B) Comparison between P19 and antisense clone AI
at day 7 after differentiation into cardiomyocytes. (C) Cardiomyo-
cyte differentiation of P19 in the presence or absence of 10 mM
B203580 from day 1 until being harvested on day 7. (D) Quanti-
ation of the levels of mRNAs in AI- and SB203580-treated P19
ells relative to P19 (see Materials and Methods). The RNA of all
amples was harvested, 5 mg was treated with DNase and reverse
transcriptase in a volume of 25 ml, and then PCR was performed on
liquots of 1 ml and fivefold serial dilutions using the primer pairs
indicated, for a number of cycles previously determined to give a
semiquantitative response. Controls were included lacking the2a; Brachy-T, Brachyury-T.
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153HSP25 and Differentiationon the other hand allowed us to test the role of HSP25 and
its phosphorylation from the earliest steps of cardiomyo-
cyte differentiation.
By immunofluorescence we have shown that a strong
HSP25 expression is localized to the cardiomyocytes which
develop in cultures of differentiating P19 cells. Rhythmic
contractions are not necessary for this expression. The
differentiation of P19 cells into mesoderm does not appear
to be affected by reduced levels of HSP25, since at day 3 the
accumulation of mRNA for the mesodermal marker,
Brachyury-T, was equivalent in P19 clones constitutively
synthesizing antisense HSP25 mRNA and normal P19
clones. Furthermore, by day 8, there were no remaining
cells positive for the embryonal marker, SSEA-1, in any of
the cultures (data not shown). In contrast, HSP25 is re-
quired for functional differentiation of P19 cardiomyocytes,
since fewer colonies of P19 with reduced HSP25 levels are
able to produce rhythmically contracting cells by day 8
when compared to nontransfected P19 or P19 containing
the hygromycin resistance vector alone. The effect appears
to be specifically related to differentiation since the alter-
ations in HSP25 protein levels did not affect the growth rate
or morphology of clones. By immunofluorescence a greatly
reduced expression of cardiac markers c-actin and desmin
was observed (Table 1), and semiquantitative RT-PCR indi-
cated that significantly reduced levels of mRNA were
present for these and other cardiac markers.
Mechanism of Action of HSP25
As mentioned in the Introduction, numerous roles have
been proposed for HSP25, and any of these may contribute
to the reduced differentiation of P19 clones expressing
antisense HSP25.
smHSP can protect cells from apoptosis, and if the
FIG. 7. The intensity and distribution of desmin staining is
altered in antisense clones but not in sense clones. Hanging drop
cultures of P19, antisense clone AI, and sense clone SU were
differentiated as described in the legend to Fig. 2 and then stained
with an antibody for desmin. The entire field of each figure was
filled with cells. Bar, 50 mm.transient expression of HSP27 during differentiation of s
Copyright © 2000 by Academic Press. All rightmbryonic stem cells is inhibited by antisense expression, a
reater number of cells undergo apoptosis (Mehlen et al.,
997). Virally delivered HSP25 can protect hearts against
ifferent inducers of apoptosis in vivo (Brar et al., 1999).
lthough we observed a certain amount of cell death during
ifferentiation, presumably due to apoptosis, the levels
ere not noticeably different in antisense or sense clones.
It is possible that the effect of HSP25 antisense is medi-
ted via cells other than the cardiomyocytes. For example,
19 require signals from endodermal cells for cardiomyo-
yte differentiation (Mummery et al., 1991; van den
ijnden-van Raaij et al., 1991). The level of HSP25 affects
he secretion of bFGF from endothelial cells (Piotrowicz et
FIG. 8. The ability of P19 cells to differentiate into beating
cardiomyocytes was greatly reduced by the presence of SB203580 at
early time points. (A) Differentiation of P19 cells by the “hanging
drops” method in the presence of 1% DMSO or its absence (2
DMSO) as described in the legend to Fig. 4, but with the addition of
10 mM SB203580 or 50 mM PD90589 for the time periods delimited
y the arrowheads. Error bars represent the standard deviation
etween duplicate dishes. (B) is similar except that differentiation
as performed in “bulk culture” (see Materials and Methods), to
llow the SB203580 to be washed away from aggregates at early
ime points before plating on tissue culture dishes, and only a
ingle dish of each sample was scored.
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154 Davidson and Morangeal., 1997), and hence the inhibition of HSP25 expression in
endodermal cells might reduce the level of growth factors
such as FGF secreted in P19 cultures. We found endodermal
cells strongly expressing the TROMA-1 epitope on the
periphery of aggregates which had differentiated into neu-
FIG. 9. The differentiation of P19 into neurons in the presence of
etinoic acid was augmented in the presence of SB203580. Cells
ere differentiated in bulk culture without inducer (P19), with
etinoic acid (RA), or in the presence of both retinoic acid and 10
mM SB203580 (RA SB); plated on day 4 in normal medium without
drugs; and harvested on day 8 for immunofluorescence with
neuron-specific antibody TuJ1 (A, B) or an immunoblot with TuJ1
antibody (C). Bar, 50 mm.
ABLE 1
he Levels of HSP25 and the Differentiation Markers Expressed in
ondifferentiated Cultures at Day 1
Cells 1 treatment
Differentiation
agent SSEA-1
P19
nondifferentiated
None 111
P19 DMSO 2
19 antisense DMSO 2
P19 1 SB203580 DMSO 2
P19 RA 2
P19 antisense RA 2
P19 1 SB203580 RA 2
Note. The relative immunofluorescence intensities are indicated
a The level of HSP25 staining in these heterogeneous differentiated c
Copyright © 2000 by Academic Press. All rightons or cardiomyocytes but not in normal P19 monolayers.
he TROMA-1 positive cells overlapped approximately
ith HSP25-positive cells also present on the periphery.
owever, antisense HSP25 expression did not noticeably
lter the number or morphology of TROMA-1-positive
ells.
One of the proposed roles of HSP25 is as a barbed-end
ctin-capping protein which can stabilizes cortical actin
laments. We found no obvious change in the organization
f c-actin filaments in cardiomyocytes formed from anti-
ense HSP25 clones, though the level of c-actin appeared to
e reduced.
An expanding body of literature implicates smHSPs in
he maintenance of intermediate filaments. Although the
ajor fraction of smHSPs is diffusely localized in the
ytoplasm, a component appears to be constitutively asso-
iated with intermediate filaments (and actin). Biochemical
echniques including cocentrifugation or immunoprecipita-
ion have demonstrated interactions between aB-crystallin
nd GFAP, vimentin (Nicholl and Quinlan, 1994; Djabali et
l., 1997), desmin (Bennardini et al., 1992), and peripherin
(Djabali et al., 1997). In fact, aB-crystallin is reported to be
major contaminant of desmin preparations (Longoni et al.,
990). These interactions appear to have functional ramifi-
ations since transfection of astrocytes with a vector ex-
ressing aB-crystallin reduced the formation of GFAP in-
lusions (Koyama and Goldman, 1999). It is possible to
isualize the colocalization of smHSPs and intermediate
laments either by heat stressing cells in culture to accen-
uate the interaction or by first extracting the soluble
omponent of smHSPs to leave a readily detectable coim-
unofluorescence. In this manner, colocalization of aB-
crystallin has been observed with GFAP and vimentin
(Perng et al., 1999; Djabali et al., 1997) and HSP25/HSP27
has been found colocalized with GFAP, vimentin, and
keratin-18 (Koyama and Goldman, 1999; Perng et al., 1999).
In cardiac tissue, aB-crystallin is localized to the Z line or
ferentiated Cultures of P19 Cells at Day 8, Compared to
hsp25
Cardiac
actin Desmin TuJ1
1 2 2 2
111a 111 111
1a 1 1
11a 1 1
2a 11
2a 11
2a 111
, 11, and 111. 2, no signal detected.Dif
by 1
ultures is only presented for the cardiac and neural cells.
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155HSP25 and DifferentiationI band (Bennardini et al., 1992; Longoni et al., 1990; van de
Klundert et al., 1998), where desmin and actin are also
localized. Strong evidence that these proteins interact in a
manner critical for cardiac function has recently been found
by Vicart et al. (1998), who showed that a point mutation of
aB-crystallin was responsible for a familial desmin myop-
athy. HSP25 localizes with aB-crystallin at the I band of
ardiac muscle and cardiomyocytes of neonates or adult
Hoch et al., 1996; Lutsch et al., 1997; van de Klundert et
l., 1998), strongly suggesting that HSP25 has an overlap-
ing role with aB-crystallin in maintaining the desmin
etwork in the heart. On the other hand, if HSP25 does play
role in maintaining the desmin network, it seems un-
ikely that this role would be essential for cardiogenesis in
ivo, since mice engineered to lack the desmin gene are
ully viable and show no defect in skeletal or cardiac muscle
evelopment before birth (Li et al., 1996; Milner et al.,
996). Furthermore, even though expression of truncated
esmin in myoblasts caused collapse of the intermediate
lament network and formation of cytoplasmic aggregates,
he differentiation of these cells was indistinguishable from
hat of control cells (Schultheiss et al., 1991).
Although desmin is not essential for cardiogenesis in
ivo, it is apparently required for muscle maintenance and
egeneration after birth, since the mice lacking desmin
xhibit severe disruption of muscle architecture and degen-
ration of myocardium (Li et al., 1996; Milner et al., 1996).
There are also a number of human neuromuscular diseases
which are known to involve aggregates and inclusions of
desmin (reviewed in Goebel, 1995) and three cases of
human myopathy have been demonstrated to be due to
desmin mutations (Goldfarb et al., 1998; Munoz-Marmol et
al., 1998). The phenotype of mutations introduced in vitro
often seems to be stronger than those in vivo (discussed
further below). For example, skeletal and smooth muscle
myogenesis was completely inhibited in desmin-null em-
bryonic bodies (Weitzer et al., 1995). Therefore, our dem-
onstration that desmin is affected in differentiating P19
cardiomyocytes lacking HSP25 may indicate that HSP25
plays an important role in vivo in organizing desmin, but
this role may only become apparent during muscle regen-
eration, for example.
HSP25 Expression during Neuronal Differentiation
In contrast to cardiomyocytes, we never detected any
expression of HSP25 in neurons formed from P19 cultures
aggregated in the presence of retinoic acid. This was unex-
pected since it has previously been published that total
HSP25 increases during neuronal differentiation of P19
(Stahl et al., 1992) and we observed expression of HSP25 on
a Western blot of neuronal cultures. On further examina-
tion we found that in P19 neuronal cultures it is the
endodermal cells which most likely contribute this HSP25.
Not surprisingly, considering that it was not expressed in
neurons, antisense reduction of HSP25 had no effect on
neuronal differentiation of P19.
Copyright © 2000 by Academic Press. All rightRecently, an increase in HSP27 levels was observed
uring in vitro dopamine-mediated differentiation of rat
lfactory neurons and a reduction in the levels of HSP27
xpression by antisense expression was found to inhibit this
ifferentiation (Mehlen et al., 1999). P19 neurons are very
imilar to normal neurons found during early development
f the embryonic neuroectoderm (Staines et al., 1994) and
ay differ from this specific subpopulation of neurons.
The Role of p38 in Cardiomyocyte Differentiation
Inhibition of p38 with the drug SB203580 prevented
beating cardiomyocytes from arising in a differentiating P19
population and resulted in significantly lower levels of
c-actin and desmin protein as detected by immunofluores-
cence (Table 1) or by RT-PCR. Similarly, SB203580 has
recently been shown to inhibit myotube formation of
skeletal muscle cell lines (Cuenda and Cohen, 1999; Zetser
et al., 1999). SB203580 had an inhibitory effect on the
accumulation of Brachyury-T mRNA observed at day 3,
indicating that p38 activity is involved in the differentia-
tion of P19 cells into mesoderm. Since there were no
remaining cells positive for the embryonal marker, SSEA-1,
in any of the differentiated cultures treated with SB203580
(data not shown), we hypothesize that the cells had com-
menced differentiation but that they are affected at an early
step. P19 apparently progress through multiple stages of
differentiation, since clones of P19 representing different
stages of mesodermal differentiation have previously been
derived from P19 (Pruitt, 1994). An alternative possibility is
that the cells had progressed to a mesodermal stage, but
SB203580 specifically inhibited the transcription of
Brachyury-T.
SB203580 is relatively specific to the a and b isoforms of
38 (reviewed in Sugden and Clerk, 1998) although at
oncentrations greater than those used here it can inhibit
ome isoforms of SAPK/JNK in cardiomyocytes (Clerk and
ugden, 1998). As a control for the specificity of SB203580,
e confirmed that PD98059, which inhibits the activation
f MEK1 (IC50 5 10 mM) and to a lesser extent MEK2 (IC50 5
50 mM) (Cohen, 1997), does not affect cardiomyocyte differ-
ntiation. This agrees with the fact that expression of a
inase-negative mutant of EGF-R (which activates the same
APK pathway) in P19 does not affect cardiac or skeletal
ifferentiation (Wu and Adamson, 1996) although it does
nhibit neuronal differentiation (Wu and Adamson, 1993).
here is evidence that activation of p38a leads to apoptosis
of cardiomyocytes, and activation of p38b leads to hyper-
trophy (Wang et al., 1998). In P19 cultures, an apparent
increase in death by apoptosis was only observed in cultures
treated continuously with SB203580 from day 1 to day 8 of
differentiation, but this increase was also observed in
PD98059-treated cultures, in which differentiation was
unaffected.
We noticed that in the presence of SB203580, the HSP25-
and TROMA-1-positive cells on the periphery of aggregates
seemed less well spread. This may reflect the role of p38 in
s of reproduction in any form reserved.
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156 Davidson and Morangeactin dynamics and cell spreading or migration (Matsumoto
et al., 1999; Rousseau et al., 1997), and the altered morphol-
ogy may conceivably affect the ability of these cells to
influence the differentiation of cardiomyocytes.
What Is the Target of p38 in Cardiomyocyte
Differentiation?
The activity of HSP25 in stabilizing or reorganizing the
actin network can be inhibited by the use of either p38
inhibitors or a nonphosphorylatable mutant of HSP25
(Huot et al., 1997; Rousseau et al., 1997). p38 acts on HSP25
via MAPKAPK-2, which is highly expressed and activated
in heart and skeletal muscle and in cultured cardiac myo-
blasts (Zu et al., 1997). In order to determine whether
HSP25 was the relevant target of p38 in our system, the
drug was added for different time periods from the start of
aggregation at day 1 to the assay time point at day 8. We
observed an effect only if SB203580 was present early, from
day 1 until day 3, which indicates that phosphorylation by
the p38 target, MAPKAPK-2, is irrelevant to the function of
the HSP25 accumulating in cardiomyocytes at day 6. There-
fore, p38 also appears to be irrelevant in terms of the actin
reorganization required during P19 cardiogenesis. It is not
known whether phosphorylation by p38 is involved in the
interaction between HSP25 and desmin, but if so, this, too,
must be irrelevant for P19 cardiogenesis.
The early (days 1 to 3) action of SB203580 in inhibiting
cardiac differentiation of P19 cells appears to rule out a
direct inhibition of transcription of the genes encoding
cardiac-specific structural proteins such as c-actin and
MLC-2a, since these accumulate at about day 6 (Rudnicki
t al., 1990). Rather, p38 activity is likely to be necessary for
ctivation of one of the transcription factors present in the
ardiomyocyte precursors, which have already been charac-
erized as p38 responsive. The MEF2C transcription factor
hich is important for muscle differentiation (Lin et al.,
997) is regulated by p38 (Zhao et al., 1999) and MEF2-
inding sites are required for p38 to modulate the transcrip-
ional activity of a muscle creatine kinase reporter gene
Zetser et al., 1999). Interestingly, overexpression of MEF2C
an substitute for DMSO in P19 differentiation (Skerjanc et
l., 1998). However, an essential activity of p38 on MEF2C
n P19 seems unlikely since, although MEF2C transcripts
re present to some degree in normal P19 cells, they
ccumulate particularly after 6 days of cardiomyocyte dif-
erentiation (Grepin et al., 1997), by which time addition of
B203580 had no effect. It remains possible that SB203580
cts on another factor expressed at early time points. For
xample, serum response factor (SRF) can be phosphory-
ated by MAPKAPK-2 (Heidenreich et al., 1999) and serum
nduction of ANF in the heart is via p38-mediated activa-
ion of an SRF partner protein, ATF6 (Thuerauf et al., 1998).
Although the in vitro P19 differentiation system serves to
eliably indicate whether a gene is likely to be involved in
n vivo differentiation, the strength of the phenotype ob-
erved may sometimes be weaker in vivo. For example, the
Copyright © 2000 by Academic Press. All rightranscription factor GATA4 was originally shown to be
ssential for the differentiation of P19 cardiomyocytes
Grepin et al., 1995, 1997), but the inhibition of cardiogen-
sis was milder or nonexistent in GATA4-deficient embry-
nic stem cells (Narita et al., 1997; Soudais et al., 1995) and
inactivation of the gene in vivo resulted in lethality only at
he time of heart tube closure (Kuo et al., 1997; Molkentin
t al., 1997). The weaker in vivo phenotype is believed to be
due to compensation by the related transcription factor
GATA6, which is apparently not expressed during P19
cardiogenesis (Grepin et al., 1995). Similarly, as mentioned
previously, the deletion of desmin from ES cells has a
stronger phenotype than deletion from mice (Li et al., 1996;
Milner et al., 1996; Weitzer et al., 1995). Although the
experiments presented here demonstrate a role for HSP25 in
cardiogenesis, it is likely that other members of the smHSP
family could successfully compensate for lack of HSP25 in
vivo. In particular, aB-crystallin, myotonic dystrophy
kinase-binding protein (MKBP), and p20 are expressed in the
heart and have very similar characteristics to HSP25 (Su-
zuki et al., 1998; Kato et al., 1994). We did not examine the
expression of these proteins in P19, but we speculate that
the residual level of differentiation observed in clones with
reduced HSP25 may be due to a partial rescue by other
smHSP.
Of course the heart also undergoes many morphological
rearrangements during its formation, which we are unable
to address using the in vitro P19 system. It would be
interesting to examine whether HSP25 is also required for
processes such as heart looping, which requires an intact
actin network (Itasaki et al., 1991).
As described in the Introduction, cardiomyocyte hyper-
trophy is an adaptive response of the heart in which
embryonic proteins such as bMHC, ANF, and skeletal
a-actin are reexpressed, and myofibrils are reorganized.
Activation of p38 appears to be required for the mainte-
nance of myofibrillar organization during hypertrophy
(Clerk et al., 1998; Zechner et al., 1997) and phosphoryla-
tion of MAPKAPK-2 and HSP25 is also observed (Clerk et
al., 1998). By virtue of the similarity between late-stage
cardiogenesis, as observed in P19 cells, and hypertrophy,
our results may suggest that HSP25 does not require phos-
phorylation by p38 in hypertrophy either, and that the roles
of HSP25 and p38 in actomyosin rearrangement, while both
being important, are independent.
In conclusion, HSP25 is not necessary for neuronal dif-
ferentiation of P19, but is essential for functional differen-
tiation of P19 into beating cardiomyocytes. Though HSP25
may have a role in the establishment of the desmin net-
work, it also seems to be needed for other aspects of early
differentiation of mesodermal cells into functional cardio-
myocytes. The p38 MAPK pathway is essential for differ-
entiation of P19 cardiomyocytes at an early stage which
does not overlap with the late increase in HSP25 expression
during cardiomyocyte differentiation. The targets of the
p38/SAPK2 pathway essential for cardiomyocyte differen-
tiation remain to be determined.
s of reproduction in any form reserved.
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